UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2016-02, Vol.62 (4), p.e1-e50

2016

Volltextzugriff (PDF)

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

Clinical infectious diseases, 2012-04, Vol.54 (8), p.1110-1122

2012

Volltextzugriff (PDF)

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2009-03, Vol.48 (5), p.503-535

2009

Volltextzugriff (PDF)

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Clinical infectious diseases, 2007-10, Vol.45 (7), p.883-893

2007

Volltextzugriff (PDF)

Cooper Medical School of Rowan University

Academic medicine, 2020-09, Vol.95 (9S A Snapshot of Medical Student Education in the United States and Canada: Reports From 145 Schools), p.S309-S312

2020

Volltextzugriff (PDF)

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

BMC infectious diseases, 2014-02, Vol.14 (1), p.97-97, Article 97

2014

Volltextzugriff (PDF)

EDITORIAL COMMENTARY: Is the Debate About Treatment of Candida parapsilosis Complex Infections With Echinocandins Much Ado About Nothing?

Clinical infectious diseases, 2014-05, Vol.58 (10), p.1422-1423

Reboli, Annette C.

2014

Volltextzugriff (PDF)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

Critical care (London, England), 2011-01, Vol.15 (5), p.R253-R253

2011

Volltextzugriff (PDF)

Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia

Infectious diseases (London, England), 2015-08, Vol.47 (8), p.584-587

2015

Volltextzugriff (PDF)

Anidulafungin versus Fluconazole for Invasive Candidiasis

The New England journal of medicine, 2007-06, Vol.356 (24), p.2472-2482

2007

Volltextzugriff (PDF)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

BMC infectious diseases, 2011-09, Vol.11 (1), p.261-261, Article 261

2011

Volltextzugriff (PDF)

Micafungin: an evidence-based review of its place in therapy

Core evidence, 2014-01, Vol.9, p.27-39

2014

Volltextzugriff (PDF)

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

PharmacoEconomics, 2011-08, Vol.29 (8), p.705-717

2011

Volltextzugriff (PDF)

Anidulafungin: when and how? The clinician's view

Mycoses, 2012-01, Vol.55 (1), p.36-44

2012

Volltextzugriff (PDF)

A comparative evaluation of properties and clinical efficacy of the echinocandins

Expert opinion on pharmacotherapy, 2007-07, Vol.8 (10), p.1479-1492

2007

Volltextzugriff (PDF)

Prevention of central venous catheter-related bloodstream infections: is it time to add simulation training to the prevention bundle?

Journal of clinical anesthesia, 2012-11, Vol.24 (7), p.555-560

2012

Volltextzugriff (PDF)

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

Mycoses, 2011-01, Vol.54 (1), p.46-51

2011

Volltextzugriff (PDF)

Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations

Current clinical microbiology reports, 2017-12, Vol.4 (4), p.218-231

2017

Volltextzugriff (PDF)

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2016-02, Vol.62 (4), p.409-417

2016

Volltextzugriff (PDF)

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2021-2024

2004

Volltextzugriff (PDF)

Roadmap for creating an accelerated three-year medical education program

Medical education online, 2017-01, Vol.22 (1), p.1396172-1396172

2017

Volltextzugriff (PDF)

Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis

The Journal of infectious diseases, 2004-06, Vol.189 (12), p.2185-2191

2004

Volltextzugriff (PDF)

A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1473-1480

2005

Volltextzugriff (PDF)

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Clinical infectious diseases, 1998-06, Vol.26 (6), p.1383-1396

1998

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(53)
Humans
(50)
Infectious Diseases
(32)
Male
(30)
Adult
(26)
Female
(25)
Microbiology
(25)
Antifungal Agents - Therapeutic Use
(21)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Middle Aged
(21)
Aged
(19)
Candidiasis
(19)
Immunology
(19)
Infections
(17)
Candida
(15)
Candidiasis - Drug Therapy
(15)
Fungal Infections
(14)
Echinocandins
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Cooper Medical School of Rowan University

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

EDITORIAL COMMENTARY: Is the Debate About Treatment of Candida parapsilosis Complex Infections With Echinocandins Much Ado About Nothing?

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia

Anidulafungin versus Fluconazole for Invasive Candidiasis

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

Micafungin: an evidence-based review of its place in therapy

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

Anidulafungin: when and how? The clinician's view

A comparative evaluation of properties and clinical efficacy of the echinocandins

Prevention of central venous catheter-related bloodstream infections: is it time to add simulation training to the prevention bundle?

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

Roadmap for creating an accelerated three-year medical education program

Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis

A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Suchergebnisse filtern